HOTH THERAPEUTICS Trademark

Trademark Overview

On Wednesday, October 14, 2020, a trademark application was filed for HOTH THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the HOTH THERAPEUTICS trademark a serial number of 90254147. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, June 21, 2024. This trademark is owned by Hoth Therapeutics, Inc.. The HOTH THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

biopharmaceutical development services in the field of development of therapies for dermatological disorders, including atopic dermatitis, eczema, chronic wounds, psoriasis, asthma, acne, diabetic foot ulcers, diabetic wounds, chronic diabetic wound healing, treatment and reduction of post-procedure infections; biopharmaceutical development services in the field of development of drugs, treatments, and therapeutics for acceleration of dermatological healing; biopharmaceutical development services in the field of development of vaccines for treatment of viruses and diseases; biopharmaceutical development services in the field of development of drugs, treatments, and therapeutics for immunotherapy
hoth therapeutics

General Information

Serial Number90254147
Word MarkHOTH THERAPEUTICS
Filing DateWednesday, October 14, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, June 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesbiopharmaceutical development services in the field of development of therapies for dermatological disorders, including atopic dermatitis, eczema, chronic wounds, psoriasis, asthma, acne, diabetic foot ulcers, diabetic wounds, chronic diabetic wound healing, treatment and reduction of post-procedure infections; biopharmaceutical development services in the field of development of drugs, treatments, and therapeutics for acceleration of dermatological healing; biopharmaceutical development services in the field of development of vaccines for treatment of viruses and diseases; biopharmaceutical development services in the field of development of drugs, treatments, and therapeutics for immunotherapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 1, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHoth Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10020
Party NameHoth Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10020

Trademark Events

Event DateEvent Description
Saturday, October 17, 2020NEW APPLICATION ENTERED
Tuesday, December 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 15, 2021ASSIGNED TO EXAMINER
Thursday, March 18, 2021NON-FINAL ACTION WRITTEN
Thursday, March 18, 2021NON-FINAL ACTION E-MAILED
Thursday, March 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 21, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 21, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, September 21, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 21, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, September 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022SOU EXTENSION 1 FILED
Tuesday, June 21, 2022SOU EXTENSION 1 GRANTED
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2022SOU EXTENSION 2 FILED
Tuesday, December 20, 2022SOU EXTENSION 2 GRANTED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 15, 2023SOU EXTENSION 3 FILED
Thursday, June 15, 2023SOU EXTENSION 3 GRANTED
Saturday, June 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 21, 2023SOU EXTENSION 4 FILED
Thursday, December 21, 2023SOU EXTENSION 4 GRANTED
Saturday, December 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2024SOU EXTENSION 5 GRANTED
Friday, June 21, 2024SOU EXTENSION 5 FILED
Monday, December 23, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

therapeutics hoth development field services biopharmaceutical diabetic drugs treatments dermatological healing treatment